NIME-CRTNCT05868616
Non-Invasive Method for Evaluation of Cardiac Resynchronization Therapy
At risk: Primary completion moved at least 11 months later.
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 3 versions: 3 with changes below. See every version on ClinicalTrials.gov ↗
- Notable Primary completion pushed from Mar 2027 to Mar 2028
- Eligibility criteria expanded, about 7 words
- Secondary endpoints: details revised at 6 of 6 entries
- Notable Primary completion date: Mar 2025 to Mar 2027v2
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Reverse remodelling at 6 months follow-up
Timeframe: 6 months
Secondary (6)
Hospitalization
Mortality
New York Heart Association (NYHA) Functional Classification
Minnesota Living with Heart Failure Questionnaire
Packer clinical composite score
Show 1 moreShow less
6 minute walk test
Arms and interventions
Group 1 - Implantation
Patients admitted for CRT implantation according to current ESC/AHA guidelines
Group 2 - 6 months control
Patients admitted for 6 months routine checkups of their CRT devices
Devices: Cardiac Resynchronization Therapy (CRT)
Sites
1 site in 1 country
- Oslo University HospitalOslo, Norway